

1. Cc-11050
1. 340019-69-4
2. Cc-11050
3. 1z08g7438a
4. Cc11050
5. Cyclopropanecarboxamide, N-(2-((1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-2,3-dihydro-3-oxo-1h-isoindol-4-yl)-
6. Cyclopropanecarboxamide, N-[2-[(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-3-oxo-1h-isoindol-4-yl]-
7. Refchem:124078
8. Unii-1z08g7438a
9. N-(2-((1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-3-oxo-2,3-dihydro-1h-isoindol-4-yl)cyclopropanecarboxamide
10. N-[2-[(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-3-oxo-1h-isoindol-4-yl]cyclopropanecarboxamide
11. (s)-n-(2-(1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-3-oxoisoindolin-4-yl)cyclopropanecarboxamide
12. Dovramilast [inn]
13. Schembl673303
14. Orb1686985
15. Chembl4297460
16. Schembl29366888
17. Schembl30701938
18. Gtpl13581
19. Amg-634
20. Qdzobxfrivoqbr-ljqanchmsa-n
21. Ex-a12042
22. Da-72891
23. Ms-28749
24. Hy-147263
25. Cs-0542404
26. H42759
27. Cyclopropyl-n-{2-[(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindolin-4-yl}carboxamide
28. N-{2-[(1s)-1-(3-ethoxy-4-methoxyphenyl)-2- (methanesulfonyl)ethyl]-3-oxo-2,3-dihydro-1h-isoindol- 4-yl}cyclopropanecarboxamide
29. N-{2-[(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methanesulfonyl)ethyl]-3-oxo-2,3-dihydro-1h-isoindol-4-yl}cyclopropanecarboxamide
| Molecular Weight | 472.6 g/mol |
|---|---|
| Molecular Formula | C24H28N2O6S |
| XLogP3 | 2.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 9 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 110 |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 823 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Phosphodiesterase 4 Inhibitors
Compounds that specifically inhibit PHOSPHODIESTERASE 4.